¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lymphoblastic transformation test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® test ÇÑ±Û °Ë»ç
¼³¸í   
  ¾î¶² ´Ù¸¥ ¹°ÁúÀ» °ËÃâ, ÃøÁ¤, »ý¼ºÇϱâ À§ÇѠƯÁ¤ÇÑ È­ÇйÝÀÀÀ» ÀÏÀ¸Å°´Âµ¥ »ç¿ëµÇ´Â ¹æ¹ý.
¿µ¹® scratch test ÇÑ±Û ³­Àý¹ý
¼³¸í   
  ÇǺθ¦ ³¯Ä«·Î¿î ¹Ù´Ã·Î ±Ü¾î ÇǺÎÀÇ ¹ÝÀÀÀ» º¸´Â °Ë»ç·Î ÇǺΠ°ú¹Î¹ÝÀÀÀ̳ª ¾Ë·¹¸£±â¸¦ ¾Ë¾Æº¸±â À§ÇÑ °Ë»çÀÌ´Ù. ¹Ù´Ã³¡¿¡ Ç׿øÀ» ¹¯Èù µÚ, ÇǺιØÀ» ±Ü¾î ¹ÝÀÀÀ» ¾Ë¾Æº»´Ù. À̶§ Ç׿øÀÌ ¾Æ´Ñ ´ëÁ¶¹°Áú(¿¹¸¦ µé¾î º¸ÅëÀÇ ¹°)À» ¹¯Èù ¹Ù´ÃÀ» °°ÀÌ ¹ÝÀÀÇÏ¿© ÇǺ馱âÁõ(dermographism) ´ÜÁö ¹Ù´ÃÀÇ ±ÜÈû¸¸À¸·Î ¾Ë·¹¸£±â °°Àº ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Çö»ó°ú °¨º°ÇؾߠÇÑ´Ù.
  
  ³­Ã», Ã»·Â¼Ò½Ç(hearing loss)
  
  Ã»°¢ÀÌ ÀúÇÏ ¶Ç´Â »ó½ÇµÈ »óÅÂ. ¿øÀΰú Á¤µµ´Â ¿©·¯ °¡ÁöÀε¥, ³­Ã»Àº ±× Á¤µµ°¡ °¡Àå ½ÉÇÑ »óÅÂÀÌ´Ù. Ã»°¢ÀÇ Àüµµ°æ·Î¿¡ Àå¾Ö°¡ ÀÖÀ» ¶§ ³­Ã»ÀÌ ÀϾ°í, ±× º´ÅͰ¡ ¿ÜÀ̵µ³ª ÁßÀÌ¿¡ Àִ °ÍÀ» ÀüÀ½³­Ã», ³»ÀÌ¿¡ Àִ °ÍÀ» °¨À½ ³­Ã»À̶ó ÇÏ¿© ±¸ºÐÇÑ´Ù. ¶Ç º´ÅÍÀÇ ÀÚ¸®¸¦ ¸í½ÃÇÏ¿© ÁßÀ̼º ³­Ã»À̳ª ¹Ì·Î¼º ³­Ã» µîÀ¸·Î ¼¼ºÐÇϱ⵵ ÇÑ´Ù.
¿µ¹® stool guaiac test ÇÑ±Û ´ëº¯ ±¸¾ÆÀÌ¾Ç °Ë»ç
¼³¸í   
  ´ëº¯³»¿¡ ÀÖÀ» ¼ö Àִ ÀáÇ÷(´«¿¡ º¸ÀÌÁö ¾Ê´Â ÃâÇ÷)À¯¹«¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, Ç÷±¸³»ÀÇ heme peroxidase¿¡ ÀÇÇØ guaiacÀÌ »êÈ­µÇ´Â ¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ´Ù. ¹æ¹ýÀº 3Àϰ£¿¡ °ÉÃÄ ÇÑ º¯¿¡¼­ 2±ºµ¥¾¿ Ã¤ÃëÇÏ¿© °Ë»çÇÑ´Ù. À§¾ç¼º ¹ÝÀÀ(°ÅÁþÀ¸·Î Ç÷¾×ÀÌ ÀÖ´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº ½Ä¹° °ú»êÈ­È¿¼Ò¸¦ ÇÔÀ¯Çϰí Àִ ȫ´ç¹«ÀÇ ¼·Ã볪 Ç÷±¸ ¼ººÐÀ» ÇÔÀ¯Çϰí Àִ °í±â ¼·Ã렵¼­ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, À§À½¼º ¹ÝÀÀ(½ÇÁ¦·Î Ç÷¾×Àº ÀÖÁö¸¸, Ç÷¾×ÀÌ ¾ø´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº È¯¿ø·ÂÀ» °¡Áö°í Àִ ºñŸ¹Î CÀÇ º¹¿ë½Ã ³ªÅ¸³¯ ¼ö ÀÖ´Ù. Æ¯È÷ À§¾ç¼º ¹ÝÀÀÀÌ ¸Å¿ì ÈçÇÏ´Ù.
¿µ¹® Rorschach Test ÇÑ±Û ·Î¸£»þÇÏ °Ë»ç
¼³¸í   
  »ç°íÀå¾Ö¿Í Á¤¼­Àå¾Ö¿¡ ¹Î°¨ÇÑ Åõ»ç°Ë»ç(projective test). °ËÀº»ö°ú ¸î°¡Áö »öÀ¸·Î ÀÌ·ç¾îÁø À×Å©¾ó·è°°Àº µµÇüÀÌ ±×·ÁÁø 10°³ÀÇ Ä«µå¸¦ ÀÌ¿ëÇÑ´Ù. ÇǰËÀÚ¿¡°Ô Ä«µå¸¦ º¸ÀÌ°í º» °Í¿¡ ´ëÇØ ¸»Çϵµ·Ï ÇÑ´Ù. ´ÙÀ½¿¡´Â ¾ó·èÀÇ ¾î´À À§Ä¡°¡ ÇǰËÀÚ°¡ ¸»ÇÑ Áö°¢´ë»óÀ» ¾Ï½ÃÇÏ´ÂÁö Ã£µµ·Ï ÇÑ´Ù. ÇǰËÀÚÀÇ ´äº¯À» ºÐ¼®Çϸ頱×ÀÇ »ç°í¿Í Á¤¼­»óÅ¿¡ ´ëÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Ù. 
¿µ¹® Mantoux test ÇÑ±Û ¸ÁÅä¿ì°Ë»ç
¼³¸í   
  ¼Ò¾Æ¿¡ ÁַΠ½Ç½ÃÇϴ °Ë»ç ¹æ¹ýÀ¸·Î, BCGÁ¢Á¾ÈÄ¿¡³ª È¤Àº °áÇÙ±Õ¿¡ ÇѹøÀ̶󵵠³ëÃâµÈ °æ¿ì¿¡ ¾ç¼º¹ÝÀÀÀ¸·Î ³ª¿Â´Ù. ¿ì¸®³ª¶ó¿¡¼­´Â »ýÈÄ 1°³¿ù¿¡ BCG¿¹¹æÁ¢Á¾À» ½ÃÇàÇϹǷΠ´ëºÎºÐ ¾ç¼ºÀ¸·Î ³ª¿À°Ô µÇ³ª, ÀÌ ¿¹¹æÁ¢Á¾À» ¹ÞÁö ¾ÊÀº »óÅ¿¡¼­ ¾ç¼ºÀ¸·Î ³ª¿À¸é, °áÇÙ±ÕÀǠħÅõ¸¦ ÀǽÉÇÒ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blastic transformation
    ¸ð¼¼Æ÷Àüȯ
  • chronic lymphoblastic leukemia/small lymphocytic lymphoma
    ¸¸¼º¸²ÇÁ¸ð±¸¹éÇ÷º´/¼Ò¸²ÇÁ±¸¸²ÇÁÁ¾
  • lymphoblastic leukemia
    ¸²ÇÁ¸ð±¸¹éÇ÷º´
  • lymphoblastic lymphoma
    ¸²ÇÁ¸ð±¸¸²ÇÁÁ¾
  • malignant transformation
    ¾Ç¼ºÀüȯ
  • radioactive transformation
    ¹æ»ç´ÉÀüȯ
  • acceptance test
    Àμö°Ë»ç
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦°Ë»ç
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • antinuclear antibody test
    Ç×ÇÙÇ×ü°Ë»ç
  • aptitude test
    Àû¼º°Ë»ç
  • articulation test
    ¹ßÀ½°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transformation
    Àüȯ, ÇüÁúÀüȯ, º¯È¯
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • transformation zone
    º¯ÇüÃþ
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • test strip
    °Ë»ç¶ì
  • test
    °Ë»ç, ½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • agglutination test
    ÀÀÁý°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶óÁ¦°Ë»ç
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • blood test
    Ç÷¾×°Ë»ç
  • blood coagulation test
    Ç÷¾×ÀÀ°í°Ë»ç
  • blood sugar test
    Ç÷´ç°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphoblastic transformation test
    ¸²ÇÁ¸ð¼¼Æ÷Àüȯ°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphoblastic leukemia
    ¸²ÇÁ¸ð±¸¹éÇ÷º´
  • lymphoblastic lymphoma
    ¸²ÇÁ¸ð±¸¸²ÇÁÁ¾
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯
  • artificial transformation
    Àΰøº¯È¯
  • isometric transformation
    µîÀ庯ȯ
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • radioactive transformation
    ¹æ»ç´ÉÀüȯ
  • transformation
    Àüȯ, ÇüÁúÀüȯ
  • abrasion test
    ¸¶¸ê½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • acceptance test
    Àμö°Ë»ç
  • achievement test
    ¼ºÃëµµ°Ë»ç
  • acid challenge test
    »êÅõ¿©°Ë»ç
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Burkitts acute lymphoblastic leukemia
    ¹öŰƮ ±Þ¼º ¸²ÇÁ¾Æ±¸¼º ¹éÇ÷º´
  • 2D FT (2D Fourier transformation)
    2Â÷¿ø Fourier º¯È¯ (2Â÷¿ø Ç»¸®¾î º¯È¯)
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ, ºÎÀüÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
  • artificial transformation
    Àΰøº¯È¯(¡­Ü¨üµ).
  • G-test=£¾gonadotropin stimulation test
    °í³ªµµÆ®·ÎÇÉ ÀÚ±ØÅ×½ºÆ®. µµÆ®·ÎÇÉÁö±Ø°Ë»ç
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • RPR test => rapid plasma reagin test
    ½Å¼ÓÇ÷À帮¾ÆÁø<°¨ÀÛÇ×ü>½ÃÇè
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • acidified serum test=Ham test
    »ê¼ºÈ­Ç÷û°Ë»ç
  • acidified-serum lysis test=Ham test
    »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • antiglobulin test = Coombs test
    Çױ۷κҸ°°Ë»ç
  • polyethylene glycol test =PEG test
    Æú¸®¿¡Æ¿·»±Û¸®Äݰ˻ç
  • ACTH stimulation test
    ACTH Àڱذ˻ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphoblastic transformation test
    ¸²ÇÁ¾Æ¼¼Æ÷Àüȯ½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute lymphoblastic leukemia
    ±Þ¼º ¸²ÇÁ¸ð¼¼Æ÷¼º ¹éÇ÷º´.
  • acute lymphoblastic leukemia
    ±Þ¼º ¸²ÇÁ¸ð¼¼Æ÷¼º ¹éÇ÷º´.
  • acute lymphoblastic leukemia=ALL
    ±Þ¼º¸²ÇÁ±¸¼º¹éÇ÷º´,
  • lymphoblastic
    ¸²ÇÁ¾Æ±¸ÀÇ
  • lymphoblastic leukcmia
    ¸²ÇÁ¾Æ±¸¼º ¹éÇ÷º´
  • lymphoblastic tissue
    ¸²ÇÁ°ü¹ß»ýÁ¶Á÷
  • lymphoma,lymphoblastic
    ¸²ÇÁ¸ð±¸¼º ¸²ÇÁÁ¾(¡­Ù½Ï¹àõ ¡­)
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ, ºÎÀüÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
  • artificial transformation
    Àΰøº¯È¯(¡­Ü¨üµ).
  • cell transformation
    ¼¼Æ÷ÇüÁúÀüȯ, ¼¼Æ÷º¯Çü
  • conformal transformation
    °øÇüº¯È¯(Ë­Ì´ËÒÌ·).
  • conformal transformation
    °øÇüº¯È¯(Íìû¡Ü¨üµ).
  • fast Fourier transformation
    °í¼Ó (ÍÔáÜ) Ǫ¸®¿¡ º¯È¯ (ܨüµ)
  • isometric transformation
    µîÀ庯ȯ(¡­Ü¨üµ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lymphoblastic tissue
    ¸²ÇÁ°ü¹ß»ýÁ¶Á÷
    [¿¾ ¿ë¾î] ÀÓÆÄ¸ð¼¼Æ÷Á¶Á÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Bachman intradermal test
    ¼±¸ðÃæÇdz»¹ÝÀÀ°Ë»ç
  • bentonite flocculation test
    º¥Å䳪ÀÌÆ®ÀÀÁý°Ë»ç
  • Casoni test
    Æ÷ÃæÇdz»¹ÝÀÀ°Ë»ç
  • circumoval precipitin test (COPT)
    Ãæ¶õÁÖÀ§Ä§°­°Ë»ç
  • intradermal test
    Çdz»¹ÝÀÀ°Ë»ç
  • Mazzotti test
    ¸¶Á¶Æ¼°Ë»ç
  • Montenegro test
    ¸óÅ״ϱ׷ΰ˻ç
  • Sabin-Feldman dye test
    (Åå¼ÒÆ÷ÀÚÃæ) »ö¼Ò¸é¿ª°Ë»ç
  • screening test
    ¼±º°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • CaCl2 transformation
    CaCl2 º¯Çü¼ú(ܨû¡âú)
  • calcium chloride transformation
    ¿°È­Ä®½· º¯Çü¼ú(ܨû¡âú)
  • closure transformation
    ºÀÇÕ º¯Çü(Üñùêܨû¡)
  • double transformation
    ÀÌÁß º¯Çü(ì£ñìܨû¡) (ÔÒ) cotransformation
  • joint transformation
    °øµ¿º¯Çü(ÍìÔÒܨû¡)
  • Kronig-Kramer transformation
    Å©·Î´Ï±×-Å©¶ó¸Ó º¯Çü(ܨû¡)
  • linear transformation
    ¼±ÇüÀüȯ(àÊû¡ï®üµ)
  • linked transformation
    ¿¬°üº¯Çü(֤μܨû¡)
  • Lobry De Bruyn-Alberta van Eckenstein transformation
    ·Îºê¸® µå ºê¸¥-¾Ë¹öŸ ¹Ý ¿¡Ä˽ºÅ¸ÀÎ º¯Çü(ܨû¡)
  • lymphocyte transformation
    ¸²ÇÁ±¸º¯Çü(ܨû¡)
  • metabolic transformation
    ´ë»ç º¯Çü(ÓÛÞóܨû¡)
  • opening transformation
    °³±¸º¯Çü(ËÒϢܨû¡)
  • transformation
    "(ÇüÁú) Àüȯ ((û¡òõ)ï®üµ), º¯Çü(ܨû¡)"
  • acrolein test
    ¾ÆÅ©·Ñ·¹ÀνÃÇè (ãËúÐ)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • 2D FT [=2D Fourier transformation]
    2Â÷¿øFourierº¯È¯
  • magnetic transformation
    ÀÚ±âÀüȯ
  • pelvis perfusion test(Whitaker test)
    ½Å¿ì°ü·ù°Ë»ç
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • contraction test
    ¼öÃà°Ë»ç
  • double blind test
    ÀÌÁ߸Ͱ˹ý
  • dye dilution test
    »ö¼ÒÈñ¼®½ÃÇè
  • guaiac test
    °úÀ̾׽ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • laboratory test
    °Ë»ç
  • pivot shift test
    ÃßÃà º¯À§½ÃÇè
  • provocation test
    À¯¹ß½ÃÇè
  • provocative test
    À¯¹ß½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LTT lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te...
PAT Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili...
CAT California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr...
TAT tetanus antitoxin; thematic apperception test; thematic aptitude test; thrombin-antithrombin complex...
CALLA Common Acute Lymphocytic(Lymphoblastic) Leukemia Antigen
  = CD10
  = Enk...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LTT Lymphocyte Transformation Test
ALL Acute lymphoblastic leukemia
ANLL Acute Non Lymphoblastic Leukemia
B-ALL B cell acute lymphoblastic leukemia
BCP ALL B-cell precursor acute lymphoblastic leukaemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute lymphoblastic leukemia
    ±Þ¼º ¸²ÇÁ¼º ¹éÇ÷º´
    1. À¯¾Æ ¹× ÀþÀº ¼ºÀο¡ È£¹ßÇÏ´Â Áúȯ. À¯¾Æ ±Þ¼º ¹éÇ÷º´ÀÇ »ó´ç¼ö¸¦ Â÷ÁöÇÑ´Ù. À¯¾Æ¿¡¼­ÀÇ È£¹ß ¿¬·ÉÀº 4¼¼ ÀüÈÄ. ÃÖ±Ù È­Çпä¹ýÀ¸·Î º´¿¡ °É¸° À¯¾ÆÀÇ 90%°¡ ¿ÏÀü Ä¡À¯µÈ´Ù. ¿¹ÈÄ´Â ¿¬·É, ¸é¿ªÇ¥ÇöÇü ±×¸®°í ¼¼Æ÷ À¯ÀüÇÐÀûÀÎ º¯È­¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ´Â´Ù. 2. ȯÀÚÀÇ 90%°¡ ¹éÇ÷±¸ ¼¼Æ÷¿¡¼­ ÇÙÇü ÀÌ»óÀ» º¸ÀδÙ. ÀϺΠ¼¼Æ÷À¯Àü º¯È­°¡ ¼ºº°, ¿¬·É, ¸é¿ªÇ¥ÇöÇü °°Àº º¯ÀÌ¿ä¼Ò¿Í »ó°ü¾øÀÌ ¿¹ÈÄ¿¡ ´ëÇÑ Á¤º¸¸¦ ÁØ´Ù. 51-60 ¿°»öü »çÀÌÀÇ °í¹è¼ö¼ºÀÌ ¿¹Èİ¡ ÁÁÀº °ÍÀº ÀÌ¹Ì Àß ¾Ë·ÁÁ® ÀÖ´Ù.
  • conformal transformation
    °øÇü º¯È¯
  • order-disorder transformation
    ±ÔÄ¢-ºÒ±ÔÄ¢ º¯ÅÂ
    ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ÀÓÀÇ·Î ¹è¿­Çϰí ÀÖ´Â ºÒ±ÔÄ¢ °ÝÀÚ¿¡¼­ ±ÔÄ¢ ¹Ù¸¥ ¹è¿­ÀÇ ±ÔÄ¢ °ÝÀÚ·Î º¯ÇÏ´Â º¯ÅÂ.
  • physical transformation
    ¹°¸®Àû º¯Çü
  • sex transformation
    ¼º Àüȯ
    ¿¬¼Ò±â¿¡ ¼º¼±À» Á¦°ÅÇÏ¸é ³²³à Áß°£ °³Ã¼³ª À̼ºÀÇ Æ¯Â¡ÀÌ ¹ßÇöµÈ´Ù.
  • transformation gauge
    º¯È¯ °ÔÀÌÁö
  • abrasion test
    ¸¶¸ê ½ÃÇè
    ¸¶¸ð¿¡ °ßµð´Â Á¤µµ¸¦ ½ÃÇèÇÏ´Â °Ë»ç.
  • acetest tablet test
    ¾Æ¼¼Å×½ºÆ® Á¤ ½ÃÇè
    ¹éÁö À§¿¡ ¿Ã·Á³õÀº ¾Æ¼¼Å×½ºÆ® Á¤¿¡ ¿ä ÇÑ ¹æ¿ïÀ» ¶³¾î¶ß¸± ¶§, ¾î´À Á¤µµÀÇ ¾Æ¼¼ÅæÀÌ Á¸ÀçÇÏ¸é ±× ¾ç¿¡ µû¶ó¼­ ¾Æ¼¼Å×½ºÆ® Á¤ÀÌ ´ãÀÚ»ö
  • acetoacetic acid test
    ¾Æ¼¼Åä ÃÊ»ê ½ÃÇè
  • achievement test
    ¼öµæ´É·Â °Ë»ç, ¼öµæ´É·Âµµ °Ë»ç
  • acid elution test
    »ê ¿ë¸® ½ÃÇè
    ÅÂ¾Æ Çì¸ð±Û·ÎºóÀÇ °ËÃâ ½ÃÇèÀ¸·Î, ½½¶óÀÌµå ±Û¶ó½º À§¿¡ °ø±â °ÇÁ¶µÈ Ç÷¾× µµÆ÷ Ç¥º»À» 80% ¸ÞŸ³î·Î °íÁ¤ÇÏ¿©,
  • acoustic reflex test
    û°¢¹Ý»ç ½ÃÇè
    û°¢¹Ý»ç ¿ªÄ¡ÀÇ ÃøÁ¤¹ýÀ¸·Î¼­ Àüµµ¼º°ú °¨°¢½Å°æ¼º ³­Ã»À» °¨º° Áø´ÜÇϰųª û½Å°æÁ¾À» Áø´ÜÇÏ´Â µ¥ ÀÌ¿ëµÈ´Ù.
  • ACTH stimulation test
    ACTH ÀÚ±Ø °Ë»ç
    Çϼöü ºÎ½ÅÇÇÁú°è ¿¹ºñ·Â°Ë»çÀÇ Çϳª. ºÎ½ÅÇÇÁúÀÚ±Ø È£¸£¸ó
  • Addis test
    ¾Æµð½º ½ÃÇè
    12½Ã°£ µ¿¾È ¿äÀÇ ÀÏÁ¤·® Áß ÀûÇ÷±¸ ¼ö, ¹éÇ÷±¸ ¼ö, »óÇǼ¼Æ÷, ¿øÁÖ, ´Ü¹é ÇÔ·®ÀÇ ÃøÁ¤. ½ÅÀå ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ »ç¿ëµÈ´Ù.
  • additional diagnostic test
    ºÎ°¡Àû Áø´Ü¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute lymphoblastic leukaemia <haematology> A rapidly progressing cancer of the blood affecting the type of white blood cell known as lymphocytes. Approximately 650 new cases are diagnosed every year in the UK and it is the most common form of childhood leukaemia.
Acronym: ALL
Origin: Gr. Haima = blood
(11 Nov 1997)
common acute lymphoblastic leukaemia <haematology, oncology> A sub-type of acute lymphoblastic leukaemia affecting cells early in the B lymphocyte lineage which accounts for about 80% of all acute lymphoblastic leukaemia.
Origin: Gr. Haima = blood
(13 Nov 1997)
lymphoblastic Pertaining to the production of lymphocytes.
(05 Mar 2000)
lymphoblastic leukaemia Acute lymphocytic leukaemia in which the abnormal cells are chiefly (or almost totally) blast forms of the lymphocytic series, or in which unusually large numbers of the immature forms occur in association with adult lymphocytes.
(05 Mar 2000)
lymphoblastic lymphoma <tumour> A diffuse lymphoma in children, with supradiaphragmatic distribution and T lymphocytes having convoluted nuclei; many patients develop acute lymphoblastic leukaemia.
(05 Mar 2000)
lymphoma, lymphoblastic A high-grade malignant lymphoma composed of a diffuse, relatively uniform proliferation of cells with round or convoluted nuclei and scanty cytoplasm. The cells are cytologically similar to the lymphoblasts seen in acute lymphocytic leukaemia, and in some cases, the disease may evolve into a leukaemic phase morphologically indistinguishable from acute t-lymphocytic leukaemia (leukaemia, T-cell, acute). Lymphoblastic lymphoma represents approximately one-third of the cases of non-hodgkin's lymphomas in children and 5% of the cases in adults. It is more prevalent in males.
(12 Dec 1998)
abiotic transformation <biochemistry> An abiotic transformation is any process in which a chemical in the environment is altered by non-biological mechanisms (such as by exposure to sunlight).
(09 Oct 1997)
bacterial transformation <microbiology> A genetics lab procedure where bacteria are induced to accept and incorporate into their genome foreign pieces of cell-less, isolated DNA, often in the form of a plasmid.
The DNA to be introduced usually contains a selectable marker so that the bacteria which successfully incorporate the DNA can be selected for.
(09 Oct 1997)
blast transformation <haematology> The morphological and biochemical changes in lymphocytes, both B and T, on exposure to antigen or to a mitogen. The cells appear to move from G0 to G1 stage of the cell cycle. They usually enlarge and proceed to S phase and mitosis later. The process probably involves receptor cross linking on the plasma membrane.
(18 Nov 1997)
genetic transformation <molecular biology> Genetic change brought about by the introduction of exogenous DNA into a cell.
See: transformation, germ line transformation, transfection.
(18 Nov 1997)
germ line transformation Micro injection of foreign DNA into an early embryo, so that it becomes incorporated into the germ line of the individual and thus stably inherited in subsequent generations of transgenic organisms. Typically, the DNA would be a reporter gene or cDNA in a vector such as a transposon, that might also carry a visible marker gene such as eye or coat colour), so that successful transformation could readily be detected.
(18 Nov 1997)
viral transformation <oncology, virology> Malignant transformation of an animal cell in culture, induced by a virus.
(18 Nov 1997)
cell transformation Morphological and physiological changes resulting from infection of an animal cell by an oncogenic virus.
(05 Mar 2000)
cell transformation, neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
(12 Dec 1998)
cell transformation, viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transformation
    º¯Çü
  • microbial transformation
    ¹Ì»ý¹° º¯È¯
  • transformation
    º¯Çü;º¯¸ð;º¯Áú
  • transformation scene
    (¸·À» ³»¸®Áö ¾Ê´Â) »¡¸® º¯ÇÏ´Â Àå¸é
  • transformation theory
    º¯Çü¼³
  • test
    ½ÃÇè,½ÃÇèÇÏ´Ù
  • Binet Simon test
    Áö³×½Ã¸ù½Ä Áö´É °Ë»ç¹ý
  • Dick test
    (ÀÇ)µñ Å×½ºÆ®(¼ºÈ«¿­ ÇǺΠ½ÃÇè)
  • Kline test
    Ŭ¶óÀÎ ½ÃÇè(¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀ)
  • New Test.
    New Testament
  • Partial Test Ban Treaty
    ºÎºÐÀû ÇÙ½ÇÇè ±ÝÁö Á¶¾à
  • Rorschach test
    ·Î¸£»þÇÏ Å×½ºÆ®(À×Å©ÀÇ ¾ó·è°£Àº ¹«ÀǹÌÇÑ ¹«´Ì¸¦ ÇØ¼®½ÃÄÑ »ç¶÷ÀÇ ¼º°ÝµîÀ» ¾Ë¾Æ³»´Â °Ë»ç)
  • Wassermann test
    ¹Ù¼­¸¸ °Ë»ç(¹ÝÀÀ);¸Åµ¶ÀÇ Ç÷û Áø´Ü
  • achievement test
    Çз°˻ç
  • acid test
    »ê½ÃÇè;¾ö¹ÐÇѽÃÇè
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á